Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

[Myasthenia gravis in dentistry].

Tjeerdsma NL, van der Kooi EL, van der Meij EH, de Visscher JGAM.

Ned Tijdschr Tandheelkd. 2018 Jul;125(7-8):375-380. doi: 10.5177/ntvt.2018.07/08.18137. Dutch.

PMID:
30015811
2.

A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.

Wohlgemuth M, Lemmers RJ, Jonker M, van der Kooi E, Horlings CG, van Engelen BG, van der Maarel SM, Padberg GW, Voermans NC.

Neurology. 2018 Jul 11. pii: 10.1212/WNL.0000000000005915. doi: 10.1212/WNL.0000000000005915. [Epub ahead of print]

PMID:
29997197
3.

Falls Are Associated With Lower Self-Reported Functional Status in Patients After Stroke.

van der Kooi E, Schiemanck SK, Nollet F, Kwakkel G, Meijer JW, van de Port I.

Arch Phys Med Rehabil. 2017 Dec;98(12):2393-2398. doi: 10.1016/j.apmr.2017.05.003. Epub 2017 Jun 3.

PMID:
28583466
4.

Respiratory function in facioscapulohumeral muscular dystrophy 1.

Wohlgemuth M, Horlings CGC, van der Kooi EL, Gilhuis HJ, Hendriks JCM, van der Maarel SM, van Engelen BGM, Heijdra YF, Padberg GW.

Neuromuscul Disord. 2017 Jun;27(6):526-530. doi: 10.1016/j.nmd.2017.03.008. Epub 2017 Mar 22.

PMID:
28416348
5.

[Sudden loss of consciousness during labour].

van Genugten LT, Morssink LP, van der Kooi EL.

Ned Tijdschr Geneeskd. 2016;160(0):A9591. Dutch.

PMID:
27900920
6.

Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy.

van den Boogaard ML, Lemmers RJLF, Balog J, Wohlgemuth M, Auranen M, Mitsuhashi S, van der Vliet PJ, Straasheijm KR, van den Akker RFP, Kriek M, Laurense-Bik MEY, Raz V, van Ostaijen-Ten Dam MM, Hansson KBM, van der Kooi EL, Kiuru-Enari S, Udd B, van Tol MJD, Nishino I, Tawil R, Tapscott SJ, van Engelen BGM, van der Maarel SM.

Am J Hum Genet. 2016 May 5;98(5):1020-1029. doi: 10.1016/j.ajhg.2016.03.013.

7.

High prevalence of incomplete right bundle branch block in facioscapulohumeral muscular dystrophy without cardiac symptoms.

van Dijk GP, van der Kooi E, Behin A, Smeets J, Timmermans J, van der Maarel S, Padberg G, Voermans N, van Engelen B.

Funct Neurol. 2014 Jul-Sep;29(3):159-65.

8.

Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement.

Rijken NH, van der Kooi EL, Hendriks JC, van Asseldonk RJ, Padberg GW, Geurts AC, van Engelen BG.

Neuromuscul Disord. 2014 Dec;24(12):1087-96. doi: 10.1016/j.nmd.2014.05.012. Epub 2014 Jun 26.

9.

Strength training and aerobic exercise training for muscle disease.

Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts AC.

Cochrane Database Syst Rev. 2013 Jul 9;(7):CD003907. doi: 10.1002/14651858.CD003907.pub4. Review.

PMID:
23835682
10.

Hypothermia after CPR prolongs conduction times of somatosensory evoked potentials.

Bouwes A, Doesborg PG, Laman DM, Koelman JH, Imanse JG, Tromp SC, van Geel BM, van der Kooi EL, Zandbergen EG, Horn J.

Neurocrit Care. 2013 Aug;19(1):25-30. doi: 10.1007/s12028-013-9856-8.

PMID:
23702693
11.

Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy.

Statland JM, McDermott MP, Heatwole C, Martens WB, Pandya S, van der Kooi EL, Kissel JT, Wagner KR, Tawil R.

Neuromuscul Disord. 2013 Apr;23(4):306-12. doi: 10.1016/j.nmd.2013.01.008. Epub 2013 Feb 11.

12.

A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study.

van der Kooi E, Klarenbeek NB, Güler-Yüksel M, Kerstens PJ, van der Lubbe PA, Westedt ML, ten Wolde S, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Jan;70(1):168-71. doi: 10.1136/ard.2010.133132. Epub 2010 Nov 29.

PMID:
21115551
13.

Strength training and aerobic exercise training for muscle disease.

Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts ACh.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003907. doi: 10.1002/14651858.CD003907.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD003907.

PMID:
20091552
14.

Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy.

van der Kooi EL, Kalkman JS, Lindeman E, Hendriks JC, van Engelen BG, Bleijenberg G, Padberg GW.

J Neurol. 2007 Jul;254(7):931-40. Epub 2007 Mar 14.

15.

No effect of folic acid and methionine supplementation on D4Z4 methylation in patients with facioscapulohumeral muscular dystrophy.

van der Kooi EL, de Greef JC, Wohlgemuth M, Frants RR, van Asseldonk RJ, Blom HJ, van Engelen BG, van der Maarel SM, Padberg GW.

Neuromuscul Disord. 2006 Nov;16(11):766-9. Epub 2006 Sep 26.

PMID:
17005397
16.

An unbiased and efficient computerised tomography method to quantify muscle and adipose tissue volume in neuromuscular patients.

van der Kooi EL, de Leeuw GE, Vlak MH, Hendriks JC, Padberg GW, Vogels OJ.

Neurol Sci. 2006 Feb;26(6):423-9.

PMID:
16601935
17.

High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders.

Hengstman GJ, van Brenk L, Vree Egberts WT, van der Kooi EL, Borm GF, Padberg GW, van Venrooij WJ, van Engelen BG.

J Neurol. 2005 May;252(5):534-7. Epub 2005 Feb 23.

PMID:
15726253
18.

Strength training and aerobic exercise training for muscle disease.

van der Kooi EL, Lindeman E, Riphagen I.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003907. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD003907.

PMID:
15674918
19.

Strength training and albuterol in facioscapulohumeral muscular dystrophy.

van der Kooi EL, Vogels OJ, van Asseldonk RJ, Lindeman E, Hendriks JC, Wohlgemuth M, van der Maarel SM, Padberg GW.

Neurology. 2004 Aug 24;63(4):702-8.

PMID:
15326246
20.

Ventilatory support in facioscapulohumeral muscular dystrophy.

Wohlgemuth M, van der Kooi EL, van Kesteren RG, van der Maarel SM, Padberg GW.

Neurology. 2004 Jul 13;63(1):176-8.

PMID:
15249635
21.

Face mask spirometry and respiratory pressures in normal subjects.

Wohlgemuth M, van der Kooi EL, Hendriks JC, Padberg GW, Folgering HT.

Eur Respir J. 2003 Dec;22(6):1001-6.

22.

Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles.

Wohlgemuth M, Lemmers RJ, van der Kooi EL, van der Wielen MJ, van Overveld PG, Dauwerse H, Bakker E, Frants RR, Padberg GW, van der Maarel SM.

Neurology. 2003 Oct 14;61(7):909-13.

PMID:
14557558
23.

Correlation of clinical function and muscle CT scan images in limb-girdle muscular dystrophy.

Vlak M, van der Kooi E, Angelini C.

Neurol Sci. 2000;21(5 Suppl):S975-7.

PMID:
11382199

Supplemental Content

Loading ...
Support Center